Nifty Pharma index ends 3.21% higher. Top gainers: COMPANY LATEST PREV CLOSE GAIN() GAIN(%) SUN PHARMA.INDS. 601.80 563.90 37.90 6.72 BIOCON 589.40 571.70 17.70 3.10 DIVI'S LAB. 1154.55 1120.20 34.35 3.07 LUPIN 836.75 811.95 24.80 3.05 CIPLA 642.75 628.30 14.45 2.30 Nifty sectoral gainers and losers BSE Sensex: Sun Pharma, YES Bank, RIL among top gainers of the day Market at close The S&P BSE Sensex ended at 37,852, up 207 points while the broader Nifty50 index settled at 11,435, up 79 points. External factors, selective intervention by RBI led to rupee's fall: Garg The government on Tuesday blamed "external factors" for the rupee's fall to an all-time low against the US dollar and said there is nothing to worry. Economic Affairs Secretary Subhash Chander Garg said external factors may ease going forward. READ MORE Sun Pharma rallies 7% as Q1 profit beats Street estimates Shares of Sun Pharmaceutical Industries have rallied 7% to Rs 600 per share on the BSE after the pharmaceutical company reported a better-than-expected consolidated net profit at Rs 9.83 billion in June quarter (Q1FY19). The company had posted a loss of Rs 4.25 billion in the same quarter year ago. READ MORE
The S&P BSE Sensex ended at 37,852, up 207 points while the broader Nifty50 index settled at 11,435, up 79 points.
In key stocks, the market heavyweight Reliance Industries (RIL) rose 2 per cent to Rs 1,210.95 levels on the BSE. Sun Pharmaceutical Industries too surged around 7 per cent to end at Rs 601.65.
The rupee breached 70 per dollar, hitting an all-time low on Tuesday after diving by Rs 1.09 to close at an all-time low of Rs 69.92 against the US dollar on Monday, bowing to a global rout in currencies on fears of an economic crisis in Turkey. It was the biggest single-day fall in almost five years.
Japan’s Nikkei held onto its early 1.1 per cent gain, while Australian stocks added 0.8 per cent. The Shanghai blue chip index was off 0.6 per cent and weighing on MSCI’s broadest index of Asia-Pacific shares outside Japan which eased 0.2 per cent.